Tag Archives: Business of Trademarks
GSK to Buy BMS’s HIV Portfolio
Drug giant GlaxoSmithKline has reached a deal to acquire Bristol-Myers Squibb’s HIV portfolio. GSK will pay $350 million up front and could pay an additional $1 billion depending on developmental and sales milestones. GSK did the deal through its subsidiary … Continue reading
Bayer Loses CTM Opposition
On 29 October 2015, OHIM’s Opposition Division of the Office dismissed Bayer’s opposition against registration of the mark SALOSPIR & Design (No. 012351458). Bayer opposed Uni-Pharma SA’s application for the mark SALOSPIR & Design for pharmaceutical preparations in Class 5 based on three … Continue reading
Purple Pill Update
Further to our post here, Judge Sue Robinson of the US District Court for the District of Delaware issued a temporary order banning Dr. Reddy’s from selling its generic version of AstraZeneca’s Nexium, after the pharmaceutical company objected to its … Continue reading
Court Cancels URBAN HOMESTEADING Trademark
In a longstanding dispute between advocates of urban farming and the Dervaes family of Pasadena, a federal district judge gave opponents of the Dervaes’ a partial victory when he ordered cancellation of the trademark for URBAN HOMESTEADING on the grounds … Continue reading
AstraZeneca Asserts Its Purple Rights
**Update here** Global pharma giant AstraZeneca has asserted its rights to its purple trademark. AstraZeneca filed a complaint at the US District Court for the District of Delaware on 28 October, claiming Indian drug maker Dr. Reddy’s Laboratories’s generic version of Nexium … Continue reading
Walmart Avoids Federal Action
Walmart has successfully avoided action by the Federal Trade Commission (“FTC”) concerning Walmart’s mislabeling of products as “Made in the U.S.A.,” when they were, in fact, not made in the U.S.A. The retailer was forced to remove “Made in the … Continue reading